| Literature DB >> 25874023 |
Marília Baierle1, Sabrina N Nascimento1, Angela M Moro1, Natália Brucker1, Fernando Freitas1, Bruna Gauer1, Juliano Durgante2, Suelen Bordignon3, Murilo Zibetti3, Clarissa M Trentini3, Marta M M F Duarte4, Tilman Grune5, Nicolle Breusing6, Solange C Garcia1.
Abstract
OBJECTIVE: Cognitive impairment reduces quality of life and is related to vascular and neurodegenerative disorders. However, there is also a close relationship between these diseases and oxidative stress. Thus, the purpose of this study was to assess whether inflammation and oxidative damage are associated with low cognitive performance in the elderly with different housing conditions.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25874023 PMCID: PMC4383403 DOI: 10.1155/2015/804198
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Baseline characteristics and prevalence of comorbidities of the studied sample.
| Variable | Institutionalized ( | Noninstitutionalized ( |
|---|---|---|
| Age, mean (SEM) | 78.8 (1.5)a | 71.2 (1.5) |
| Years of education, mean (SEM) | 4.8 (0.5)a | 11.1 (0.8) |
| Gender, frequency (%) | ||
| Male | 9 (28.1) | 11 (44.0) |
| Female | 23 (71.9) | 14 (56.0) |
| Barthel Index, mean (SEM) | 95.4 (1.6)a | 98.4 (1.4) |
| Charlson Comorbidity Index, mean (SEM) | 3.8 (0.2)a | 3.2 (0.2) |
| Comorbidities (%) | ||
| Hypertension | 18 (56.2) | 18 (72.0) |
| Diabetes mellitus type 2 | 6 (18.7) | 5 (20.0) |
| Dyslipidemia | 2 (6.2) | 6 (24.0) |
| Osteoporosis | 6 (18.7) | 1 (4.0) |
| Hypothyroidism | 0 (0.0) | 3 (12.0) |
| Arrhythmia | 1 (3.1) | 1 (4.0) |
| Chronic obstructive pulmonary disease | 1 (3.1) | 2 (8.0) |
| Gastritis | 1 (3.1) | 2 (8.0) |
| Benign prostatic hyperplasia | 0 (0.0) | 2 (8.0) |
| Glaucoma | 1 (3.1) | 1 (4.0) |
| Chronic renal failure | 1 (3.1) | 0 (0.0) |
| Chronic venous insufficiency | 1 (3.1) | 0 (0.0) |
| Hyperuricaemia | 1 (3.1) | 0 (0.0) |
| Osteoarthritis | 1 (3.1) | 0 (0.0) |
| Angina pectoris | 1 (3.1) | 0 (0.0) |
The values are expressed as mean (SEM) or frequency (percentage).
aP < 0.05.
Oxidative status in the studied groups of the elderly.
| Biomarkers | Institutionalized ( | Noninstitutionalized ( |
|---|---|---|
| MDA ( | 7.59 ± 0.17a | 6.22 ± 0.27 |
| PCO (nmol mg−1 protein) | 0.37 ± 0.01b | 0.30 ± 0.01 |
| GPx ( | 9.51 ± 0.53b | 17.31 ± 0.94 |
The values were adjusted for age and Charlson Comorbidity Index and expressed as mean ± SEM.
a P < 0.05.
b P < 0.001.
Exogenous antioxidants in the studied groups of the elderly.
| Analyte | Institutionalized ( | Noninstitutionalized ( | Reference value# |
|---|---|---|---|
| Lycopene ( | 0.53 ± 0.04b | 0.86 ± 0.06 | 0.4–0.6 |
|
| 0.62 ± 0.06a | 0.77 ± 0.07 | 0.19–1.58 |
| Retinol ( | 2.41 ± 0.11b | 3.32 ± 0.16 | 1.05–2.80 |
|
| 29.70 ± 1.17b | 37.70 ± 1.79 | 12–42 |
| Vitamin C (mg L−1) | 7.35 ± 0.64 | 7.93 ± 0.78 | 4–15 |
The values were adjusted for age and expressed as mean ± SEM.
#According to Burtis et al., Tietz Fundamentals of Clinical Chemistry, St. Louis: Saunders/Elsevier, 2008 [32].
a P < 0.05.
b P < 0.001.
Figure 1Levels of inflammation markers in the institutionalized (n = 32) and noninstitutionalized elderly (n = 25). (a) IL-1β; (b) IL-6; (c) IL-10; (d) TNF-α; and (e) IFN-γ. The values were adjusted for age and Charlson Comorbidity Index and expressed as mean ± SEM. * P < 0.001.
Correlation coefficients between inflammation markers versus oxidative damage and antioxidant biomarkers (n = 57).
| Cytokines | MDA ( | PCO (nmol mg−1 protein) | GPx activity ( |
|---|---|---|---|
| IL-1 |
|
|
|
| IL-6 (pg mL−1) |
|
|
|
| TNF- |
|
|
|
| IFN- |
|
|
|
Cognitive performance of the studied groups of the elderly.
| Instrument | Institutionalized ( | Noninstitutionalized ( |
|---|---|---|
| MMSE | 21.36 (8–29)b | 27.32 (20–30) |
| Verbal Fluency | 12.14 (2–26)a | 17.32 (7–31) |
| Boston Naming Test | 10.73 (5–15)b | 13.91 (9–15) |
The values were adjusted for age and Charlson Comorbidity Index and expressed as mean (range).
a P < 0.05.
b P < 0.01.
Correlation coefficients among factors involved in oxidative status and cognitive parameters (n = 52).
| Factors | MMSE | Verbal Fluency | Boston Naming Test |
|---|---|---|---|
| MDA ( |
|
|
|
| PCO (nmol mg−1 protein) |
|
|
|
| GPx ( |
|
|
|
| Lycopene ( |
|
|
|
Figure 2Inflammation markers and cognitive performance. Spearman's correlations among inflammation markers and MMSE performance: (a) IL-1β and (b) TNF-α. In each analysis, n = 52.
Multivariate analysis: factors associated with cognition performance (regression model).
| Variable |
MMSE |
Verbal Fluency |
Boston Naming Test | |||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| GPx ( | 0.221 | 0.116 | 0.218 | 0.254 | 0.385 | 0.029 |
| Lycopene ( | −0.055 | 0.695 | 0.153 | 0.304 | 0.152 | 0.265 |
| PCO (nmol·mg−1 protein) | −0.104 | 0.487 | 0.018 | 0.906 | −0.168 | 0.242 |
| MDA ( | −0.070 | 0.656 | 0.024 | 0.887 | 0.078 | 0.609 |
| TNF- | 0.389 | 0.337 | 0.327 | 0.445 | 0.121 | 0.752 |
| IL-1 (pg·mL−1) | −0.291 | 0.474 | −0.217 | 0.613 | 0.062 | 0.872 |
| Charlson Comorbidity Index (score) | 0.117 | 0.403 | −0.072 | 0.632 | −0.146 | 0.284 |
| Education (years) | 0.532 | 0.002 | 0.391 | 0.030 | 0.239 | 0.123 |
β: standardized coefficient beta; R 2: determination coefficient.